ArkBios, Ziresovir

ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Arkbio New York China

View original content:https://www.prnewswire.co.uk/news-releases/arkbios-ziresovir-included-into-pediatric-rsv-drug-priority-list-by-who-302505283.html

en | boerse | 67919838 |